Q&As

Neurology Learning Network spoke with Sami Khella, MD, who gave a talk on new and emerging therapies for amyloidosis at the American Neurological Association’s 145th Annual Meeting.
In a recent systematic review, investigators examined the effects of medical marijuana on neurological symptoms among patients with Huntington disease. Senior study author Rana Zeine, MD, PhD, MBA, answered our questions about the findings in this review and their clinical implications.
Mahsa Dadar, PhD, answers our questions about her new study that suggested diffusely abnormal white matter regions in the brain evolve into focal white matter lesions over time in secondary progressive multiple sclerosis, which in turn may be associated with clinical disease progression.
Recent findings from 2 independent cohorts have reinforced the importance of preserving REM sleep. Study author Eileen Leary, PhD, answers our questions about the findings and their implications.
Elysa Widjaja, MD, MPH, answered our questions about her new study, which suggested that more than 50% of children who undergo MRI-guided laser interstitial thermal therapy have seizure freedom at 1 year. These findings were presented at the American Epilepsy Society virtual meeting, AES2020.
Neurology Learning Network spoke with Steven M. Greenberg, MD, PhD, who gave a talk at the American Neurological Association’s 145th Annual Meeting about recent research and treatment advances in cerebral amyloid angiopathy.
Shiv Saidha, MBBCh, answered our questions about his study, which suggests that elevated body mass index may be associated with accelerated ganglion cell + inner plexiform layer atrophy in the absence of overt metabolic comorbidities among patients with multiple sclerosis.
Brain structural changes during preclinical Alzheimer disease appear to have a biphasic trajectory, according to new findings. Neurology Learning Network spoke with first author Victor Montal, PhD(c), MSc, about these findings and their implications.
Neurology Learning Network spoke with Rachel Saunders-Pullman, MD, MPH; Tanya Simuni, MD; and Tara Hastings, MA, who recently discussed clinical genetic testing for Parkinson disease at the American Neurological Association’s 145th Annual Meeting.
At the ANA’s 145th Annual Meeting, P. James Dyck, MD, discussed recent research and treatment advances in hereditary transthyretin amyloidosis. After Dr Dyck’s presentation, Neurology Learning Network caught up with him about important research and treatment advances in this field.